Rocket Pharmaceuticals

ISIN US77313F1066

 | 

WKN A2JA9Q

Market cap (in EUR)
668.31 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 668.31 m
EPS, EUR -2.45
P/B ratio 1.81
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 0.00 m
Net income, EUR -239.20 m
Profit margin -

What ETF is Rocket Pharmaceuticals in?

There are 25 ETFs which contain Rocket Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Rocket Pharmaceuticals is the Global X Genomics & Biotechnology UCITS ETF.

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee Stock savings plans
0.99€
1000
View offer*
1.00€
2500
View offer*
0.00€
2500
View offer*
0.00€
1200
View offer*
0.00€
500
View offer*
Show all offers
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
1.50€
1.50%
0.00€
View offer*
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.